Latest MSD News & Updates

See the latest news and media coverage for MSD. We track all announcements, press releases, and industry mentions in real time, all in one place.

MSD

Research-intensive biopharmaceutical company

msd.com

Headquarters: Rahway, United States
Company type: Public company
Number of employees: 35,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about MSD

In short: MSD achieved 5% sales growth to $16.6 billion in Q2 2026 and advanced its oncology and HIV pipelines through key regulatory approvals.

Company announcements

August 4 MSD

MSD announced second-quarter 2026 financial results and pipeline milestones

Total sales rose 5% to $16.6 billion, but a Terns acquisition charge drove a GAAP loss. The FDA approved LIPFENDRA.

July 22 MSD

MSD announces positive Phase 3 trial results for once-weekly HIV treatment

The ISL/LEN regimen showed noninferiority to daily oral standard of care at 48 weeks in two trials.

July 1 MSD

MSD is advancing its largest pipeline with AI

It leverages AI and data science to accelerate drug discovery for new patient solutions.

June 22 MSD

MSD's tulisokibart met Phase 3 UC trial endpoints

The anti-TL1A antibody achieved clinical remission at 12 weeks in patients with moderately to severely active ulcerative colitis, with no safety concerns identified.

Media coverage

August 19 Yahoo Finance

Moderna shares soar as skin cancer jab results published

A new cancer jab can reduce the risk of death and late-stage melanoma skin cancer from returning, it has been announced as experts hailed the...

August 6 Yahoo Finance

MSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data

This study miss marks a setback for Gilead’s Trodelvy expansion plans, which include both mono and c...

August 5 Yahoo Finance

MSD posts a victory and defeat for anti-TL1A in skin condition and rare lung disease

MSD is currently evaluating tulisokibart in six different indications following the drug's discontinuation in SSc-ILD.

August 5 RTTNews

Health Canada Approves Merck's Keytruda With Enfortumab Vedotin For Bladder...

Merck & Co., Inc. (MRK), known as MSD outside the United States and Canada, said on Wednesday that Health Canada approved its cancer drug Keytruda...

Never miss news about MSD

Track MSD and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

MSD competitors & trending companies

Browse news for competitors to MSD and other trending companies.